iRegene Therapeutics (Chengdu) Co., Ltd.

About iRegene Therapeutics (Chengdu) Co., Ltd.

iRegene is a passionate team committed to developing first-in-class therapies for patients with major incurable diseases. Their mission is to redefine medicine for future generations by re-programming cell fate or function, prioritizing fast-acting and disease-reversing therapies that are accessible to as many patients as possible.

Products & Services

iReMeta:A discovery platform powered by AI algorithms for omic analysis, leveraging information from patients to create precise and distinctive models.

iReChem:A deep learning-assisted virtual screening tool for drug discovery.

iReXam:A platform for compounds validation.

iReDita:A tool for gene editing and reporter cell lines.

iReCena:A platform for designing exosomes for therapeutics delivery.

NouvNeu001:A therapy for Parkinson's Disease, currently in Phase II trials in China (completion by Q4 2026) and Phase I trials in the US (patient enrolment by Q3 2025).

NouvNeu003:A therapy for Early-onset Parkinson's, with IND approved by NMPA on Dec 11, 2023, and Phase I dosing completed in Mar 2025.

NouvNeu004:A therapy for Multiple System Atrophy, with IND applications submitted to NMPA and FDA in Q2 2025.

NouvSight001:A therapy for Retinal Degenerative Diseases, with FDA Orphan Drug Designation approved on Mar 20, 2024, and IND submission planned for Q4 2025.

Specialties

AI-powered drug discovery Gene editing Therapeutics delivery via exosomes Neurological and retinal disease therapies Deep learning for virtual screening Compounds validation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B+ T: - FT: Series B+	A: 40000000 MR: - FA: RMB 300 million (~USD 40M) FAN: 40000000	D: 2025-09-04 FD: 2025-09-04	4 investors

Series B+ Latest

2025-09-04

$40.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News